Developing medical countermeasures for exposure to hazardous chemicals
Wake Forest University Vesicant Exposure Resource and Coordination Core
This study is working on finding better treatments and protective measures for people who have been exposed to harmful chemicals, using advanced models to understand how these chemicals affect the body.
Quick facts
| Grant type | NIH-funded research |
|---|---|
| Study type | NIH-funded research |
| Funding institution | Wake Forest University Health Sciences NIH-funded |
| Lab location | 1 site (Winston-Salem, United States) |
| Project ID | NIH-10937787 on NIH RePORTER |
What this research studies
This research focuses on creating effective medical countermeasures for individuals exposed to highly toxic chemicals. It aims to establish a resource and coordination core that provides advanced experimental models and analytical methods to support the development of these countermeasures. The project will utilize a variety of preclinical models, including studies on corneal, dermal, and pulmonary injuries, to better understand the effects of these hazardous substances. Patients may benefit from improved treatments and protective measures against chemical exposures.
Who could benefit from this research
Good fit: Ideal candidates for this research include individuals who have been exposed to hazardous chemicals or are at risk of such exposure.
Not a fit: Patients who have not been exposed to hazardous chemicals or do not have related health concerns may not benefit from this research.
Why it matters
Potential benefit: If successful, this research could lead to the development of new treatments that protect patients from the harmful effects of chemical exposures.
How similar studies have performed: Other research has shown success in developing medical countermeasures for chemical exposures, indicating that this approach has potential for meaningful advancements.
Where this research is happening
Winston-Salem, United States
- Wake Forest University Health Sciences — Winston-Salem, United States (Active)
Researchers
- Principal investigator: Mcnutt, Patrick Michael — Wake Forest University Health Sciences
- Study coordinator: Mcnutt, Patrick Michael
About this research
- This is an active NIH-funded research project — typically early-stage science, not a clinical trial accepting patient enrollment.
- Some NIH-funded labs run parallel clinical studies or seek volunteers for related work. To check, contact the principal investigator or institution listed above.
- For full project details, budget, and progress reports, visit the official NIH RePORTER page below.